B

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Key Account Manager - BeLux

Account ManagementPosted on Nov 12
Full-timeBrussels, Belgium

About the Job

Requirements

  • At least five years of experience as a product or sales specialist in the vaccine market.
  • A bachelor's or master's degree in Life Sciences, Biomedical Sciences, Pharmacy, or Medicine.
  • A proven track record in a field-based role, spending up to 80% of the time with clients.
  • Proficiency in English, Flemish, and French is essential.

Responsibilities

  • Manage key accounts in Belgium and Luxembourg and help achieve commercial goals in the region.
  • Serve as the main contact for a portfolio of key accounts and key opinion leaders, including scientific societies.
  • Build and maintain strong relationships, implement strategic account plans, identify growth opportunities, manage tenders, and promote products.
  • Report to the Country Director of France & Benelux, help achieve sales targets, and support the implementation of marketing initiatives.
  • Develop long-term relationships with key accounts and key opinion leaders.
  • Analyse the market to identify new business opportunities.
  • Work with the France & Benelux team to achieve sales targets.
  • Share product information with healthcare professionals.
  • Gather market insights and help develop appropriate customer communication materials.
  • Manage distribution logistics, participate in tenders, and coordinate product releases with relevant agencies.
  • Contribute to the rolling forecast and marketing budget.

About the Company

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Bavarian Nordic develops, manufactures, and sells vaccines and cancer immunotherapies. Its vaccines and immunotherapies aim to train the body's immune system to recognize and attack cancer cells or infectious agents. The company operates as a fully integrated biotechnology business, handling development, production, and commercialization, and it collaborates with partners and licensing agreements to bring its products to market. A key differentiator is its track record, including European marketing authorization for an Ebola vaccine and a licensing deal for a COVID-19 vaccine, plus ongoing partnerships. The company's goal is to improve global health by reducing the risk of infectious diseases and by improving cancer treatment outcomes.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
1994

Recently Posted Jobs

Explore more opportunities at Bavarian Nordic

See more jobs